# Tirzepatide and metabolic surgery: complementary approaches for multimodal management of MASLD.

> PubMed lists PMID 41258966 in Hepatology international as Letter, Comment, with publication-date metadata of 2025-11-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41258966-tirzepatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-04-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41258966-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41258966-tirzepatide-v1.json
- Content SHA-256: `a57ae34f68b6ac45bee0ce30e99d1c61631c5061a84d89c0d8a18c332b82234e`

## Claims and source pins

### Headline

Tirzepatide and metabolic surgery: complementary approaches for multimodal management of MASLD. ([`pubmed-observation-pmid-41258966-2026-04-27-30178300daa1`](#source-pubmed-observation-pmid-41258966-2026-04-27-30178300daa1))

### Summary

PubMed lists PMID 41258966 in Hepatology international as Letter, Comment, with publication-date metadata of 2025-11-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41258966-2026-04-27-30178300daa1`](#source-pubmed-observation-pmid-41258966-2026-04-27-30178300daa1))

### Paragraph 1

PubMed lists PMID 41258966 in Hepatology international as Letter, Comment, with publication-date metadata of 2025-11-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41258966-2026-04-27-30178300daa1`](#source-pubmed-observation-pmid-41258966-2026-04-27-30178300daa1))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41258966-2026-04-27-30178300daa1`](#source-pubmed-observation-pmid-41258966-2026-04-27-30178300daa1))

## Sources

<a id="source-pubmed-observation-pmid-41258966-2026-04-27-30178300daa1"></a>
- **Tirzepatide and metabolic surgery: complementary approaches for multimodal management of MASLD. · retained source version 1:2026-04-27:current:30178300daa1e9698346f08b937a549c6c2bc040359d214907b0595b9ffdc852** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41258966/) (`pubmed-observation-pmid-41258966-2026-04-27-30178300daa1`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Tirzepatide and metabolic surgery: complementary approaches for multimodal management of MASLD." Version 1, published 2026-08-16. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41258966-tirzepatide-v1.json SHA-256: a57ae34f68b6ac45bee0ce30e99d1c61631c5061a84d89c0d8a18c332b82234e.